Hepion Pharmaceuticals Files 8-K on Security Holder Vote
Ticker: CTRVP · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1583771
| Field | Detail |
|---|---|
| Company | Hepion Pharmaceuticals, Inc. (CTRVP) |
| Form Type | 8-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Hepion Pharma filed an 8-K for a shareholder vote - details TBD.
AI Summary
Hepion Pharmaceuticals, Inc. filed an 8-K on March 10, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the vote itself, such as proposals or outcomes, but serves as a notification of such an event.
Why It Matters
This filing indicates that important decisions requiring shareholder approval have been or will be made by Hepion Pharmaceuticals, Inc., which could impact the company's future direction.
Risk Assessment
Risk Level: low — The filing is a procedural notification of a shareholder vote without immediate financial or operational disclosures.
Key Players & Entities
- Hepion Pharmaceuticals, Inc. (company) — Registrant
- March 10, 2025 (date) — Filing date and earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-36856 (identifier) — SEC File Number
- 46-2783806 (identifier) — IRS Employer Identification No.
- 55 Madison Ave Suite 400- PMB# 4362 Morristown , New Jersey 07960 (address) — Principal executive offices
- (732) 902-400 (phone_number) — Registrant's telephone number
- ContraVir Pharmaceuticals, Inc. (company) — Former company name
- 20130806 (date) — Date of name change
FAQ
What specific matters were submitted to a vote of Hepion Pharmaceuticals, Inc.'s security holders?
The 8-K filing does not specify the exact proposals or matters that were submitted to a vote of security holders.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on March 10, 2025.
What is the principal executive office address for Hepion Pharmaceuticals, Inc.?
The principal executive offices are located at 55 Madison Ave Suite 400- PMB# 4362 Morristown, New Jersey 07960.
What was Hepion Pharmaceuticals, Inc. formerly known as?
Hepion Pharmaceuticals, Inc. was formerly known as ContraVir Pharmaceuticals, Inc.
What is the SEC file number for Hepion Pharmaceuticals, Inc.?
The SEC file number for Hepion Pharmaceuticals, Inc. is 001-36856.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 regarding Hepion Pharmaceuticals, Inc. (CTRVP).